Consolidated Balance Sheets - USD ($) $ in Millions		Mar. 31, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents		$ 4,424	$ 5,081
Investments		731	920
Accounts receivable, net		16,003	15,071
Inventories		3,500	3,722
Other current assets		1,042	1,283
Assets of businesses held for sale		9,693	10,057
Total current assets		35,393	36,134
Long-term investments		17,693	18,438
Reinsurance recoverables		4,937	4,970
Deferred policy acquisition costs		719	677
Property and equipment		3,661	3,692
Goodwill		45,804	45,811
Other intangible assets		33,714	34,102
Other assets		2,541	2,728
Separate account assets		8,148	8,337
TOTAL ASSETS		152,610	154,889
Liabilities
Current insurance and contractholder liabilities		5,673	5,318
Pharmacy and other service costs payable		15,235	15,309
Accounts payable		6,632	6,655
Accrued expenses and other liabilities		7,833	7,322
Short-term debt		2,173	2,545
Liabilities of businesses held for sale		6,116	6,423
Total current liabilities		43,662	43,572
Non-current insurance and contractholder liabilities		12,167	12,563
Deferred tax liabilities, net		8,110	8,346
Other non-current liabilities		3,346	3,762
Long-term debt		31,013	31,125
Separate account liabilities		8,148	8,337
TOTAL LIABILITIES		106,446	107,705
Contingencies — Note 18
Redeemable noncontrolling interests		55	54
Shareholders' equity
Common stock	[1]	4	4
Additional paid-in capital		29,736	29,574
Accumulated other comprehensive loss		(1,492)	(884)
Retained earnings		33,420	32,593
Less: Treasury stock, at cost		(15,581)	(14,175)
TOTAL SHAREHOLDERS' EQUITY		46,087	47,112
Other noncontrolling interests		22	18
Total equity		46,109	47,130
Total liabilities and equity		$ 152,610	$ 154,889

[1] Par value per share, $0.01; shares issued, 396 million as of March 31, 2022 and 394 million as of December 31, 2021; authorized shares, 600 million.